Bromperidol
From Wikipedia, the free encyclopedia
Bromperidol (4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one MW: 420.315 g/mol, MF: C21H23BrFNO2) a butyrophenone derivative, is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia. Bromperidol was discovered at Janssen Pharmaceutica in 1966.
[edit] See also
[edit] References
- Poldinger W, Bures E, Haage H, Clinical study with bromperidol, a new butyrophenone derivative, Int Pharmacopsychiatry. 1977;12(1):20-4.
- Dubinsky B, McGuire JL, Niemegeers CJ, Janssen PA, Weintraub HS, McKenzie BE, Bromperidol, a new butyrophenone neuroleptic: a review, Psychopharmacology (Berl). 1982;78(1):1-7.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
